Maintaining dendritic cell viability in culture

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 264-267

  Vremec, David ^a   Hansen, Jacinta ^a   Strasser, Andreas ^a,b   Acha Orbea, Hans ^c   Zhan, Yifan ^a   O'Keeffe, Meredith ^d   Shortman, Ken ^a,b,d  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d BURNET INSTITUTE   (Australia)

Author keywords

Cytokines and DC survival; DC death; DC death pathways; PDC death

Indexed keywords

CD135 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; PROTEIN BCL 2; CYTOKINE;

ADULT; ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BONE MARROW; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CROSS PRESENTATION; CULTURE MEDIUM; DENDRITIC CELL; FEMALE; GENETIC MANIPULATION; HALF LIFE TIME; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID PROGENITOR CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; TURNOVER TIME; ANIMAL; C57BL MOUSE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; MICE, INBRED C57BL; SIGNAL TRANSDUCTION;

EID: 84912046932     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.07.011     Document Type: Article

References (21)

1. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Köntgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735-1738.
2. Fuertes Marraco S.A., Scott C.L., Bouillet P., Ives A., Masina S., Vremec D., Jansen E.S., O'Reilly L.A., Schneider P., Fasel N., Shortman K., Strasser A., Acha-Orbea H. Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS ONE 2011, 6:e20189.
3. Grouard G., Rissoan M.-C., Filgueira L., Durand I., Banchereau J., Liu Y.-J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997, 185:1101-1112.
4. Guimond M., Veenstra R.G., Grindler D.J., Zhang H., Cui Y., Murphy R.D., Kim S.Y., Na R., Hennighausen L., Kurtulus S., Erman B., Matzinger P., Merchant M.S., Mackall C.I. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and nitch size of CD4+ T cells. Nat. Immunol. 2009, 10:149-157.
5. Kamath A., Pooley J., O'Keeffe M., Vremec D., Zhan Y., Lew A., D'Amico A., Wu L., Tough D., Shortman K. The development, maturation and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000, 165:6762-6770.
6. Kingston D., Schmid M.A., Onai N., Obata-Onai A., Baumjohann D., Manz M.G. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009, 114:835-843.
7. Maraskovsky E., Brasel K., Teepe M., Roux E.R., Lyman S.D., Shortman K., McKenna H.J. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 1996, 184:1953-1962.
8. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005, 174:6592-6597.
9. Ogilvy S., Metcalf D., Gibson L., Bath M.L., Harris A.W., Adams J.M. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:14943-21498.
10. + dendritic cells only after microbial stimulus. J. Exp. Med. 2002, 196:1307-1319.
11. O'Keeffe M., Grumont R.J., Hochrein H., Fuchsberger M., Gugasyan R., Vremec D., Shortman K., Gerondakis S. Distinct roles for the NF-kB1 and c-Rel transcription factors in the differentiation of plasmacytoid and conventional dendritic cells activated by TLR-9 signals. Blood 2005, 106:3457-3464.
12. Sathe P., Pooley J., Vremec D., Mintern J., Jin J.-O., Wu L., Kwak J.-Y., Villadangos J.A., Shortman K. The acquisition of antigen cross-presentation function by newly formed dendritic cells. J. Immunol. 2011, 186:5184-5192.
13. Sathe P., Vremec D., Wu L., Corcoran L., Shortman K. Convergent differentiation: myeloid and lymphoid pathways to murine plasmacytoid dendritic cells. Blood 2013, 121:11-19.
14. Strasser A., Harris A.W., Cory S. bcl-2 Transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991, 67:889-899.
15. Strasser A., Cory S., Adams J.M. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011, 30:3667-3683.
16. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1998, 335:440-442.
17. Villunger A., Michalak E.M., Coultas L., Müllauer F., Böck G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 2003, 302:1036-1038.
18. Vogt T.K., Link A., Perrin J., Finke D., Luther S.A. Novel function for interleukin-7 in dendritic cell development. Blood 2009, 113:3961-3968.
19. Vremec D., O'Keeffe M., Wilson A., Ferrero I., Koch U., Radtke F., Scott B., Hertzog P., Villadangos J., Shortman K. Factors determining the spontaneous activation of splenic dendritic cells in culture. Innate Immun. 2011, 17:338-352.
20. Vremec D., Segura E. The purification of large numbers of antigen presenting dendritic cells from mouse spleen. Methods Mol. Biol. 2013, 960:327-350.
21. Waskow C., Liu K., Darrasse-Jeze G., Guermonprez P., Ginhoux F., Merad M., Shengelia T., Yao K., Nussenzweig M. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 2008, 9:676-683.